about
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and developme...
Read More
0.80
-0.01
(-1.23%)
295.8K
XNAS Volume
XNAS 12 Mar, 2026 12:31 PM (EDT)
Board Meeting
The latest board meeting for MaxCyte Inc took place on 11 Mar 2026, for the purpose of MaxCyte Inc Fourth Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
MaxCyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..